Shares of Halozyme Therapeutics, Inc. ( NASDAQ:HALO – Get Rating ) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $31.67 and last traded at $31.81, with a volume of 368240 shares trading hands. The stock had previously closed at $32.63. Analyst Upgrades and Downgrades HALO has been the subject of a number of recent research reports. JMP Securities reissued a 'market outperform' rating and set a $66.00 price objective (up previously from $62.00) on shares of Halozyme Therapeutics in a research report on Wednesday, February 22nd.

https://www.dailypolitical.com/2023/05/02/halozyme-therapeutics-nasdaqhalo-hits-new-52-week-low-at-31-67.html

#dailypolitical